Linda Yakarino joins the health technology platform EMED as CEO after leaving X

The next role of Linda Yakarino yet Departure X as an executive president will be another executive role in Population Health EMEDStarting AI building a technical platform for patients who use the GLP-1S.

Yaccarino has been a long -term executive director at NBCUNIVERSAL, but she left to join X as an executive president for two years, where she managed to get a Positive effect On the revenue of the turbulent ads revenue for the social network, despite its joint approach by Elon Musk to reduce the trivia of content.

Although Yaccarino does not have experience in health technology, EMED said in a press release that she sought it for “its uninterrupted ability to negotiate new partnerships”-it certainly helps that its majestic period in X made her known in the world of technology, and attract more holidays towards startup.

EMED previously It produced a technical platform designed to use with Covid-19 antigen tests at home, and direct users through the process of managing these tests properly. Now, EMED focuses on the GLP-1S, the category of medicines like OzemPIC, which can be used in both weight management and type 2 diabetes treatment.

“To be a pioneer in the health care market today, companies need to have a fearful perseverance that allows them not only to grow, but also to be brave enough to move forward and redefine a whole industry”, “Yaccarino He said In a press release. “We are in a very good position to be that leader is stubborn, and our Saudis towards our final goal of improving the results of global health care through our leading services and platforms.”